GYRE logo

Gyre Therapeutics (GYRE) Free Cash Flow

Annual FCF

$17.31 M
+$11.63 M+204.74%

December 31, 2023


Summary


Performance

GYRE Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGYREcash flowmetrics:

Quarterly FCF

$1.03 M
+$7.98 M+114.82%

September 30, 2024


Summary


Performance

GYRE Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGYREcash flowmetrics:

TTM FCF

-$2.23 M
-$4.58 M-195.14%

September 30, 2024


Summary


Performance

GYRE TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGYREcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

GYRE Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+204.7%-0.5%-112.9%
3 y3 years+40.7%-88.0%-125.9%
5 y5 years+40.7%-88.0%-125.9%

GYRE Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+204.7%-88.0%+114.8%-112.9%at low
5 y5-yearat high+204.7%-88.0%+114.8%-112.9%at low
alltimeall timeat high+204.7%-88.0%+114.8%-112.9%at low

Gyre Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.03 M(-114.8%)
-$2.23 M(-195.1%)
Jun 2024
-
-$6.95 M(-361.9%)
$2.35 M(-79.3%)
Mar 2024
-
$2.65 M(+156.3%)
$11.35 M(-34.4%)
Dec 2023
$17.31 M
$1.03 M(-81.5%)
$17.31 M(+6.4%)
Sep 2023
-
$5.61 M(+172.8%)
$16.27 M(+52.6%)
DateAnnualQuarterlyTTM
Jun 2023
-
$2.06 M(-76.1%)
$10.66 M(+23.9%)
Mar 2023
-
$8.61 M(+46.6%)
$8.61 M(+46.6%)
Dec 2022
$5.68 M(-53.8%)
-
-
Mar 2022
-
$5.87 M
$5.87 M
Dec 2021
$12.30 M
-
-

FAQ

  • What is Gyre Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Gyre Therapeutics?
  • What is Gyre Therapeutics annual FCF year-on-year change?
  • What is Gyre Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Gyre Therapeutics?
  • What is Gyre Therapeutics quarterly FCF year-on-year change?
  • What is Gyre Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Gyre Therapeutics?
  • What is Gyre Therapeutics TTM FCF year-on-year change?

What is Gyre Therapeutics annual free cash flow?

The current annual FCF of GYRE is $17.31 M

What is the all time high annual FCF for Gyre Therapeutics?

Gyre Therapeutics all-time high annual free cash flow is $17.31 M

What is Gyre Therapeutics annual FCF year-on-year change?

Over the past year, GYRE annual free cash flow has changed by +$11.63 M (+204.74%)

What is Gyre Therapeutics quarterly free cash flow?

The current quarterly FCF of GYRE is $1.03 M

What is the all time high quarterly FCF for Gyre Therapeutics?

Gyre Therapeutics all-time high quarterly free cash flow is $8.61 M

What is Gyre Therapeutics quarterly FCF year-on-year change?

Over the past year, GYRE quarterly free cash flow has changed by -$5000.00 (-0.48%)

What is Gyre Therapeutics TTM free cash flow?

The current TTM FCF of GYRE is -$2.23 M

What is the all time high TTM FCF for Gyre Therapeutics?

Gyre Therapeutics all-time high TTM free cash flow is $17.31 M

What is Gyre Therapeutics TTM FCF year-on-year change?

Over the past year, GYRE TTM free cash flow has changed by -$19.54 M (-112.89%)